In 2023, cerebrovascular disease mortality in Japan was [value], forming the base year for the projections. The forecasted data from 2024 to 2028 indicates a consistent decline in mortality rates, decreasing from 95.76 to 88.45 thousand deaths. The year-on-year variations show progressive reductions, signaling a positive trend towards improvement in public health measures and preventive care. The compound annual growth rate (CAGR) over these five years is -1.9%, reflecting a slow but steady decline in mortality.
Future trends to watch for include advancements in medical technology and healthcare policies aimed at early detection and management of cerebrovascular conditions. Additionally, demographic shifts in Japan's aging population may influence mortality rates, necessitating continued monitoring and adaptation of healthcare strategies.
